Figure 7
Figure 7. DCs matured with LPS/R848 agonists displaying reduced expression of CD83, CD80, and/or CD86 prime a response with reduced ability to produce effector cytokines. CD8+ T cells primed by the indicated DC subpopulations were restimulated with 10 μg/mL of Melan-A26-35 peptide 9 days after priming, and intracellular IL2, IFNγ, and TNF production were analyzed simultaneously. Bars indicate the mean proportion of total responding CD8+ T cells producing the cytokines indicated (± SEM). Data are combined from 2 donors generated in independent experiments (A) and representative of 2 independent sorting experiments (B). However, for the DC-D phenotype, the limited number of DCs generated after cytokine maturation permitted establishment of only one priming well, so SEM could not be calculated for this population.

DCs matured with LPS/R848 agonists displaying reduced expression of CD83, CD80, and/or CD86 prime a response with reduced ability to produce effector cytokines. CD8+ T cells primed by the indicated DC subpopulations were restimulated with 10 μg/mL of Melan-A26-35 peptide 9 days after priming, and intracellular IL2, IFNγ, and TNF production were analyzed simultaneously. Bars indicate the mean proportion of total responding CD8+ T cells producing the cytokines indicated (± SEM). Data are combined from 2 donors generated in independent experiments (A) and representative of 2 independent sorting experiments (B). However, for the DC-D phenotype, the limited number of DCs generated after cytokine maturation permitted establishment of only one priming well, so SEM could not be calculated for this population.

Close Modal

or Create an Account

Close Modal
Close Modal